BCTXL
BriaCell Therapeutics Corp. Warrant expiring 2031NASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
1.54
52W High
$1.40
52W Low
$0.61
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About BriaCell Therapeutics Corp. Warrant expiring 2031
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-31.92M |
| Operating Margin | 0.00% |
| Return on Equity | -175.30% |
| Return on Assets | -90.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $7.86M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
112.02%
HV 20-Day
103.71%
HV 30-Day
97.50%
HV 60-Day
119.37%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCTXL and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026